Abstract
This randomized, double-blind, placebo-controlled study evaluated midazolam syrup for reducing discomfort from intravenous placement in children 9 months to 6 years. Parents and observers rated the child's discomfort by using visual analogue scales. Median parents' pain scores were significantly lower in the midazolam than the placebo group (P =.002). Midazolam effectively reduces discomfort associated with intravenous insertion.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Oral
-
Catheterization, Central Venous / adverse effects*
-
Child
-
Child, Preschool
-
Double-Blind Method
-
Female
-
Humans
-
Hypnotics and Sedatives / administration & dosage*
-
Hypnotics and Sedatives / therapeutic use*
-
Infant
-
Male
-
Midazolam / administration & dosage*
-
Midazolam / therapeutic use*
-
Pain / etiology*
-
Pain / prevention & control*
-
Pain Measurement
-
Premedication*
-
Prospective Studies
Substances
-
Hypnotics and Sedatives
-
Midazolam